Veracyte (VCYT) Tops Q2 EPS by 9c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.09 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $72.9 million versus the consensus estimate of $68.08 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
• Nike names former Pfizer CFO David Denton as new finance chief